KRISTALLFORMEN

European patent · EP4403223 · In force

Register entry

Publication number
EP4403223
Application number
EP24151934
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 5, 2015
Published
Jul 24, 2024
Granted
May 13, 2026
Protection ends at the latest
Jun 4, 2035
Next annual fee due
Jun 30, 2027
IPC classes
C07K 5/083 (2006.01)
A61P 31/14 (2006.01)
A61K 38/12 (2006.01)
Priority
US 201462008786 P 06.06.2014
Divided from
EP15803592
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 3, 2026

    Holder’s address changed

    Owner
    AbbVie Inc., 1 North Waukegan Road, V0377, Chicago, IL 60064, USA → AbbVie Inc., 1 N. Waukegan Road, North Chicago, IL 60064, USA

    Published in Swissreg on 03.08.2026

  2. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. May 19, 2026

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 19.05.2026

  4. May 13, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.05.2026

Parties

Holder

Abbvie Inc.

AbbVie Inc.

1 N. Waukegan Road, North Chicago, IL 60064, US

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

CHEN, Shuang

Gurnee, 60031, US

GATES, Bradley D.

Mt. Prospect, 60056, US

SHEIKH, Ahmad Y.

Deerfield, 60015, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.